Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptococcal Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific... Research Beam Model: Research Beam Product ID: 153550 2500 USD New
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014

 
  • Category : Pharmaceuticals
  • Published On : November  2014
  • Pages : 76
 
 
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptococcal Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cryptococcal Meningitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Cryptococcal Meningitis 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cryptococcal Meningitis Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
TTY Biopharm Company Limited 31
Clinical Trial Overview of TTY Biopharm Company Limited 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Liposome Company, Inc 33
Clinical Trial Overview of Liposome Company, Inc 33
Alkermes Plc 34
Clinical Trial Overview of Alkermes Plc 34
Clinical Trial Overview of Top Institutes / Government 35
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
St. George's University of London 36
Clinical Trial Overview of St. George's University of London 36
University of Minnesota 37
Clinical Trial Overview of University of Minnesota 37
University of Oxford 38
Clinical Trial Overview of University of Oxford 38
University of Zimbabwe-Parirenyatwa Clinical Research Center 39
Clinical Trial Overview of University of Zimbabwe-Parirenyatwa Clinical Research Center 39
Department of Biotechnology, India 40
Clinical Trial Overview of Department of Biotechnology, India 40
French National Agency for Research on AIDS and Viral Hepatitis 41
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 41
Five Key Clinical Profiles 42
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76
List Of Tables
List of Tables
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cryptococcal Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cryptococcal Meningitis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Cryptococcal Meningitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cryptococcal Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Cryptococcal Meningitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Cryptococcal Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Cryptococcal Meningitis Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Cryptococcal Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by TTY Biopharm Company Limited, 2014* 31
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Liposome Company, Inc, 2014* 33
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Plc, 2014* 34
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. George's University of London, 2014* 36
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 37
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 38
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zimbabwe-Parirenyatwa Clinical Research Center, 2014* 39
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Biotechnology, India, 2014* 40
Cryptococcal Meningitis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 41
List Of Figures
List of Figures
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cryptococcal Meningitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cryptococcal Meningitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cryptococcal Meningitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cryptococcal Meningitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Cryptococcal Meningitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Cryptococcal Meningitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Cryptococcal Meningitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Cryptococcal Meningitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 75